|
Memantine is an important medicine for curing the Alzheimer disease.
In October 2003, the US Food and Drug Administration (FDA) approved
Memantine for the treatment of Alzheimer's disease. They conduct so
many clinical test and trials for finding the quality of product,
security of the patient and the working of Memantine by including
more than 400 Alzheimer patients from different part of the United
States.
They are happy to found that the working of Namenda is some thing
different and special than any other drugs for Alzheimer's disease.
The mild and controllable side effects and better result at better
time are some of the attractive factors that they identified. Due to
these factors FDA in United States forced to give the approval for
Namenda.
This approval is really good for both the Alzheimer patients of US
and also for the Memantine. Due to the approval this pill can sale
in all part of the United States. Other than sales they also can
manufacture the drug in any part of the United States with out any
other limitation and restriction. Food and Drug Administration give
very importance for both Alzheimer's disease and also for Namenda.
They are happy with the working and result of Memantine, but at the
same time they are afraid whether in the future Memantine will not
work properly with the Alzheimer disease. For avoiding this they
give a strict notice to the producers of Memantine for giving very
importance in the researches and findings for new generation Namenda.
|
